OLUWATOBI OGUNBAYO: Open Payments
NPI 1245019421 · MANCHESTER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 24 payments from 7 companies in 2025. Trend: 2023 $157 · 2024 $1,536 · 2025 $973
Food & beverage: $973
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $250 |
| Lundbeck LLC | 12 | $203 |
| ABBVIE INC. | 3 | $121 |
| Alkermes, Inc. | 1 | $121 |
| E.R. Squibb & Sons, L.L.C. | 1 | $95 |
| Neurocrine BioSciences, Inc. | 1 | $93 |
| Otsuka America Pharmaceutical, Inc. | 1 | $91 |
Products named: REXULTI, INVEGA SUSTENNA, VRAYLAR, LYBALVI, COBENFY.
Industry payments across NH — which companies pay providers there.
